世界の全身性エリテマトーデス治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Systemic Lupus Erythematosus Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4930
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、全身性エリテマトーデス治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗マラリア薬、非ステロイド性抗炎症薬、コルチコステロイド、その他）、用途別市場規模（病院薬局、小売薬局、オンライン販売）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・全身性エリテマトーデス治療の市場動向
・企業の競争状況、市場シェア
・全身性エリテマトーデス治療の種類別市場規模と予測2016-2027（抗マラリア薬、非ステロイド性抗炎症薬、コルチコステロイド、その他）
・全身性エリテマトーデス治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン販売）
・全身性エリテマトーデス治療の北米市場規模2016-2027（アメリカ、カナダ）
・全身性エリテマトーデス治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・全身性エリテマトーデス治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・全身性エリテマトーデス治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・全身性エリテマトーデス治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、F. Hoffmann-La Roche、Pfizer、AstraZeneca、Merck、Bristol-Myers Squibb、Anthera Pharmaceuticals、ImmuPharma、Aurinia Pharmaceuticals）
・結論

Market Analysis and Insights: Global Systemic Lupus Erythematosus Treatment Market
The global Systemic Lupus Erythematosus Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Systemic Lupus Erythematosus Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Systemic Lupus Erythematosus Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Systemic Lupus Erythematosus Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Systemic Lupus Erythematosus Treatment market.

Global Systemic Lupus Erythematosus Treatment Scope and Market Size
Systemic Lupus Erythematosus Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Lupus Erythematosus Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antimalarial Drugs
Non-steroidal Anti-inflammatory Drugs
Corticosteroids
Other

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Sales

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
F. Hoffmann-La Roche
Pfizer
AstraZeneca
Merck
Bristol-Myers Squibb
Anthera Pharmaceuticals
ImmuPharma
Aurinia Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Lupus Erythematosus Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antimalarial Drugs
1.2.3 Non-steroidal Anti-inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Other
1.3 Market by Application
1.3.1 Global Systemic Lupus Erythematosus Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Sales
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Systemic Lupus Erythematosus Treatment Market Perspective (2016-2027)
2.2 Systemic Lupus Erythematosus Treatment Growth Trends by Regions
2.2.1 Systemic Lupus Erythematosus Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Systemic Lupus Erythematosus Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Systemic Lupus Erythematosus Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Systemic Lupus Erythematosus Treatment Industry Dynamic
2.3.1 Systemic Lupus Erythematosus Treatment Market Trends
2.3.2 Systemic Lupus Erythematosus Treatment Market Drivers
2.3.3 Systemic Lupus Erythematosus Treatment Market Challenges
2.3.4 Systemic Lupus Erythematosus Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Systemic Lupus Erythematosus Treatment Players by Revenue
3.1.1 Global Top Systemic Lupus Erythematosus Treatment Players by Revenue (2016-2021)
3.1.2 Global Systemic Lupus Erythematosus Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Systemic Lupus Erythematosus Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Systemic Lupus Erythematosus Treatment Revenue
3.4 Global Systemic Lupus Erythematosus Treatment Market Concentration Ratio
3.4.1 Global Systemic Lupus Erythematosus Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Lupus Erythematosus Treatment Revenue in 2020
3.5 Systemic Lupus Erythematosus Treatment Key Players Head office and Area Served
3.6 Key Players Systemic Lupus Erythematosus Treatment Product Solution and Service
3.7 Date of Enter into Systemic Lupus Erythematosus Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Systemic Lupus Erythematosus Treatment Breakdown Data by Type
4.1 Global Systemic Lupus Erythematosus Treatment Historic Market Size by Type (2016-2021)
4.2 Global Systemic Lupus Erythematosus Treatment Forecasted Market Size by Type (2022-2027)

5 Systemic Lupus Erythematosus Treatment Breakdown Data by Application
5.1 Global Systemic Lupus Erythematosus Treatment Historic Market Size by Application (2016-2021)
5.2 Global Systemic Lupus Erythematosus Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Systemic Lupus Erythematosus Treatment Market Size (2016-2027)
6.2 North America Systemic Lupus Erythematosus Treatment Market Size by Type
6.2.1 North America Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021)
6.2.2 North America Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027)
6.2.3 North America Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2027)
6.3 North America Systemic Lupus Erythematosus Treatment Market Size by Application
6.3.1 North America Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021)
6.3.2 North America Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027)
6.3.3 North America Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2027)
6.4 North America Systemic Lupus Erythematosus Treatment Market Size by Country
6.4.1 North America Systemic Lupus Erythematosus Treatment Market Size by Country (2016-2021)
6.4.2 North America Systemic Lupus Erythematosus Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Systemic Lupus Erythematosus Treatment Market Size (2016-2027)
7.2 Europe Systemic Lupus Erythematosus Treatment Market Size by Type
7.2.1 Europe Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021)
7.2.2 Europe Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027)
7.2.3 Europe Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2027)
7.3 Europe Systemic Lupus Erythematosus Treatment Market Size by Application
7.3.1 Europe Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021)
7.3.2 Europe Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027)
7.3.3 Europe Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2027)
7.4 Europe Systemic Lupus Erythematosus Treatment Market Size by Country
7.4.1 Europe Systemic Lupus Erythematosus Treatment Market Size by Country (2016-2021)
7.4.2 Europe Systemic Lupus Erythematosus Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size (2016-2027)
8.2 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Type
8.2.1 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Application
8.3.1 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Region
8.4.1 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Systemic Lupus Erythematosus Treatment Market Size (2016-2027)
9.2 Latin America Systemic Lupus Erythematosus Treatment Market Size by Type
9.2.1 Latin America Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2027)
9.3 Latin America Systemic Lupus Erythematosus Treatment Market Size by Application
9.3.1 Latin America Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2027)
9.4 Latin America Systemic Lupus Erythematosus Treatment Market Size by Country
9.4.1 Latin America Systemic Lupus Erythematosus Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Systemic Lupus Erythematosus Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size (2016-2027)
10.2 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Type
10.2.1 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Application
10.3.1 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Country
10.4.1 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Systemic Lupus Erythematosus Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Systemic Lupus Erythematosus Treatment Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Systemic Lupus Erythematosus Treatment Introduction
11.3.4 Pfizer Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Systemic Lupus Erythematosus Treatment Introduction
11.4.4 AstraZeneca Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Systemic Lupus Erythematosus Treatment Introduction
11.5.4 Merck Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Systemic Lupus Erythematosus Treatment Introduction
11.6.4 Bristol-Myers Squibb Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Anthera Pharmaceuticals
11.7.1 Anthera Pharmaceuticals Company Details
11.7.2 Anthera Pharmaceuticals Business Overview
11.7.3 Anthera Pharmaceuticals Systemic Lupus Erythematosus Treatment Introduction
11.7.4 Anthera Pharmaceuticals Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021)
11.7.5 Anthera Pharmaceuticals Recent Development
11.8 ImmuPharma
11.8.1 ImmuPharma Company Details
11.8.2 ImmuPharma Business Overview
11.8.3 ImmuPharma Systemic Lupus Erythematosus Treatment Introduction
11.8.4 ImmuPharma Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021)
11.8.5 ImmuPharma Recent Development
11.9 Aurinia Pharmaceuticals
11.9.1 Aurinia Pharmaceuticals Company Details
11.9.2 Aurinia Pharmaceuticals Business Overview
11.9.3 Aurinia Pharmaceuticals Systemic Lupus Erythematosus Treatment Introduction
11.9.4 Aurinia Pharmaceuticals Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021)
11.9.5 Aurinia Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Systemic Lupus Erythematosus Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antimalarial Drugs
Table 3. Key Players of Non-steroidal Anti-inflammatory Drugs
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Other
Table 6. Global Systemic Lupus Erythematosus Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Systemic Lupus Erythematosus Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Systemic Lupus Erythematosus Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Systemic Lupus Erythematosus Treatment Market Share by Regions (2016-2021)
Table 10. Global Systemic Lupus Erythematosus Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Systemic Lupus Erythematosus Treatment Market Share by Regions (2022-2027)
Table 12. Systemic Lupus Erythematosus Treatment Market Trends
Table 13. Systemic Lupus Erythematosus Treatment Market Drivers
Table 14. Systemic Lupus Erythematosus Treatment Market Challenges
Table 15. Systemic Lupus Erythematosus Treatment Market Restraints
Table 16. Global Systemic Lupus Erythematosus Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Systemic Lupus Erythematosus Treatment Market Share by Players (2016-2021)
Table 18. Global Top Systemic Lupus Erythematosus Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Lupus Erythematosus Treatment as of 2020)
Table 19. Ranking of Global Top Systemic Lupus Erythematosus Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Systemic Lupus Erythematosus Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Systemic Lupus Erythematosus Treatment Product Solution and Service
Table 23. Date of Enter into Systemic Lupus Erythematosus Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Systemic Lupus Erythematosus Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Systemic Lupus Erythematosus Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Systemic Lupus Erythematosus Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Systemic Lupus Erythematosus Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Systemic Lupus Erythematosus Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Systemic Lupus Erythematosus Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Systemic Lupus Erythematosus Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Systemic Lupus Erythematosus Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Systemic Lupus Erythematosus Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Systemic Lupus Erythematosus Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Systemic Lupus Erythematosus Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Systemic Lupus Erythematosus Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Systemic Lupus Erythematosus Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Systemic Lupus Erythematosus Treatment Product
Table 66. GlaxoSmithKline Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021) & (US$ Million)
Table 67. GlaxoSmithKline Recent Development
Table 68. F. Hoffmann-La Roche Company Details
Table 69. F. Hoffmann-La Roche Business Overview
Table 70. F. Hoffmann-La Roche Systemic Lupus Erythematosus Treatment Product
Table 71. F. Hoffmann-La Roche Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021) & (US$ Million)
Table 72. F. Hoffmann-La Roche Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Systemic Lupus Erythematosus Treatment Product
Table 76. Pfizer Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Systemic Lupus Erythematosus Treatment Product
Table 81. AstraZeneca Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Systemic Lupus Erythematosus Treatment Product
Table 86. Merck Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Bristol-Myers Squibb Company Details
Table 89. Bristol-Myers Squibb Business Overview
Table 90. Bristol-Myers Squibb Systemic Lupus Erythematosus Treatment Product
Table 91. Bristol-Myers Squibb Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021) & (US$ Million)
Table 92. Bristol-Myers Squibb Recent Development
Table 93. Anthera Pharmaceuticals Company Details
Table 94. Anthera Pharmaceuticals Business Overview
Table 95. Anthera Pharmaceuticals Systemic Lupus Erythematosus Treatment Product
Table 96. Anthera Pharmaceuticals Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021) & (US$ Million)
Table 97. Anthera Pharmaceuticals Recent Development
Table 98. ImmuPharma Company Details
Table 99. ImmuPharma Business Overview
Table 100. ImmuPharma Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021) & (US$ Million)
Table 101. ImmuPharma Recent Development
Table 102. Aurinia Pharmaceuticals Company Details
Table 103. Aurinia Pharmaceuticals Business Overview
Table 104. Aurinia Pharmaceuticals Systemic Lupus Erythematosus Treatment Product
Table 105. Aurinia Pharmaceuticals Revenue in Systemic Lupus Erythematosus Treatment Business (2016-2021) & (US$ Million)
Table 106. Aurinia Pharmaceuticals Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Lupus Erythematosus Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antimalarial Drugs Features
Figure 3. Non-steroidal Anti-inflammatory Drugs Features
Figure 4. Corticosteroids Features
Figure 5. Other Features
Figure 6. Global Systemic Lupus Erythematosus Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Sales Case Studies
Figure 10. Systemic Lupus Erythematosus Treatment Report Years Considered
Figure 11. Global Systemic Lupus Erythematosus Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Systemic Lupus Erythematosus Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Systemic Lupus Erythematosus Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Systemic Lupus Erythematosus Treatment Market Share by Regions (2022-2027)
Figure 15. Global Systemic Lupus Erythematosus Treatment Market Share by Players in 2020
Figure 16. Global Top Systemic Lupus Erythematosus Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Lupus Erythematosus Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Systemic Lupus Erythematosus Treatment Revenue in 2020
Figure 18. Global Systemic Lupus Erythematosus Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Systemic Lupus Erythematosus Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Systemic Lupus Erythematosus Treatment Market Share by Type (2016-2027)
Figure 22. North America Systemic Lupus Erythematosus Treatment Market Share by Application (2016-2027)
Figure 23. North America Systemic Lupus Erythematosus Treatment Market Share by Country (2016-2027)
Figure 24. United States Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Systemic Lupus Erythematosus Treatment Market Share by Type (2016-2027)
Figure 28. Europe Systemic Lupus Erythematosus Treatment Market Share by Application (2016-2027)
Figure 29. Europe Systemic Lupus Erythematosus Treatment Market Share by Country (2016-2027)
Figure 30. Germany Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Systemic Lupus Erythematosus Treatment Market Share by Region (2016-2027)
Figure 40. China Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Systemic Lupus Erythematosus Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Systemic Lupus Erythematosus Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Systemic Lupus Erythematosus Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Systemic Lupus Erythematosus Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Systemic Lupus Erythematosus Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Systemic Lupus Erythematosus Treatment Business (2016-2021)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Systemic Lupus Erythematosus Treatment Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Systemic Lupus Erythematosus Treatment Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Systemic Lupus Erythematosus Treatment Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Systemic Lupus Erythematosus Treatment Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Systemic Lupus Erythematosus Treatment Business (2016-2021)
Figure 65. Anthera Pharmaceuticals Revenue Growth Rate in Systemic Lupus Erythematosus Treatment Business (2016-2021)
Figure 66. ImmuPharma Revenue Growth Rate in Systemic Lupus Erythematosus Treatment Business (2016-2021)
Figure 67. Aurinia Pharmaceuticals Revenue Growth Rate in Systemic Lupus Erythematosus Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Global Cutaneous Lupus Erythematosus (CLE) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4079 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、皮膚エリテマトーデス（CLE）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、抗ヒスタミン薬、抗生物質、コルチコステロイド、その他）、用途別市場規模（病院、診療所、外来外科...

世界の皮膚エリテマトーデス治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Lupus Erythematosus Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4080 2021年6月 125Pages
QYResearch社発行の本調査レポートでは、皮膚エリテマトーデス治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（レチノイド、コルチコステロイド、免疫抑制剤、抗マラリア薬、その他）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地...

世界の全身性強皮症治療市場規模・現状・予測（2021年-2027年）

Global Systemic Scleroderma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4931 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、全身性強皮症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、ホスホジエステラーゼ5阻害剤-PHA、エンドセリン受容体拮抗薬、プロスタサイクリン類似体、カルシウムチャネル遮断薬、その他）...

世界の全身性炎症反応症候群治療市場規模・現状・予測（2021年-2027年）

Global Systemic Inflammatory Response Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4929 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、全身性炎症反応症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（髄膜炎、尿路感染症（UTI）、肺炎、自己免疫疾患、その他）、用途別市場規模（病院・外来手術センター、専門クリニック、その他）、主...

世界の全身放射線療法市場規模・現状・予測（2021年-2027年）

Global Systemic Radiotherapy Market Size, Status and Forecast 2021-2027
QFJ1-5357 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、全身放射線療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈内放射線療法、経口放射線療法、点滴放射線療法）、用途別市場規模（病院、独立放射線治療センター）、主要地域別市場規模（北米、アメリカ、欧...

世界の全身性強皮症治療薬市場規模・現状・予測（2021年-2027年）

Global Systemic Scleroderma Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6029 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、全身性強皮症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、ホスホジエステラーゼ5阻害剤-PHA、エンドセリン受容体拮抗薬、プロスタサイクリン類似体、カルシウムチャネル遮断薬、その他...

世界の全身性抗生物質市場規模・現状・予測（2021年-2027年）

Global Systemic Antibiotics Market Size, Status and Forecast 2021-2027
QFJ1-4928 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、全身性抗生物質の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（βラクタム・βラクタマーゼ阻害剤、キノロン、マクロライド、その他）、用途別市場規模（病院、専門クリニック、在宅医療、その他）、主要地域別市...

世界の全身性アミロイドーシス市場規模・現状・予測（2021年-2027年）

Global Systemic Amyloidosis Market Size, Status and Forecast 2021-2027
QFJ1-4927 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、全身性アミロイドーシスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（原発性全身性アミロイドーシス（PSA）、続発性全身性アミロイドーシス、その他）、用途別市場規模（病院、診療所、研究所、その他）、主...

世界のリウマチ疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Rheumatic Disorders Drug Market Size, Status and Forecast 2021-2027
QFJ1-5995 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、リウマチ疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍壊死因子-α作用型、インターロイキン・インターロイキン受容体作用型、プロテインキナーゼ作用型、細胞表面抗原作用型、ホルモン・ホルモ...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の皮膚エリテマトーデス（CLE）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Lupus Erythematosus (CLE) Treatment Market The global Cutaneous Lupus Erythematosus (CLE) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
世界の皮膚エリテマトーデス治療市場規模・現状・予測（2021年-2027年） Lupus erythematosus (LE) is a typical autoimmune connective tissue disease that is more common in women aged 15 to 40 years. Use more anti-malarial drugs. Market Analysis and Insights: Global Cutaneous Lupus Erythematosus Treatment Market The global Cutaneous Lupus Erythematosus Treatment market siz…
世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
世界の全身性炎症反応症候群治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Systemic Inflammatory Response Syndrome Treatment Market The global Systemic Inflammatory Response Syndrome Treatment market size is projected to reach US$ 11740 million by 2027, from US$ 8346.7 million in 2020, at a CAGR of 4.5% during 2021-2027. With industry-s…
世界の全身性強皮症治療薬市場規模・現状・予測（2021年-2027年） Systemic scleroderma is an autoimmune disorder that affects the skin and internal organs . It is characterized by the buildup of scar tissue (fibrosis) in the skin and other organs. The fibrosis is caused by the body's production of too much collagen, which normally strengthens and supports connecti…